Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Heart failure is associated with cardiac hypertropy, atheiosclerosis, myocardial infarction, valvular heart disease and hypertension. Many researches has focused on development of cardiotonics for treating heart failure. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2011 - 6 pages - $500
Nov 2010 - 40 pages - $500
May 2011 - 15 pages - $125
Mar 2008 - 250 pages - $3,995
May 2011 - 396 pages - $2,265
May 2011 - 23 pages - $125
May 2011 - 15 pages - $250
May 2011 - 15 pages - $250
Sep 2010 - 25 pages - $125
Sep 2010 - 25 pages - $125
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us